In the BioHarmony Drug Report Database

"Preview" Icon

Prednisolone tebutate

Hydeltra-tba (prednisolone tebutate) is a small molecule pharmaceutical. Prednisolone tebutate was first approved as Hydeltra-tba on 1982-01-01. It is used to treat adrenal insufficiency, ankylosing spondylitis, asthma, atopic dermatitis, and berylliosis amongst others in the USA.

 

Trade Name

 

Hydeltra-tba
 

Common Name

 

prednisolone tebutate
 

ChEMBL ID

 

CHEMBL1200909
 

Indication

 

adrenal insufficiency, ankylosing spondylitis, asthma, atopic dermatitis, berylliosis, brain neoplasms, collagen diseases, conjunctivitis, dermatitis herpetiformis, edema, erythema multiforme, hemolytic anemia, hypercalcemia, inflammation, leukemia, multiple sclerosis, mycosis fungoides, nephrotic syndrome, pemphigus, pulmonary tuberculosis, rheumatic diseases, sarcoidosis, serum sickness, synovitis, systemic lupus erythematosus, thrombocytopenia, thyroiditis, ulcerative colitis, uveitis
 

Drug Class

 

Prednisone and prednisolone derivatives

Image (chem structure or protein)

Prednisolone tebutate structure rendering